Metastasis is the deadliest aspect of cancer, and IGF2BP2 has been shown to promote tumor metastasis by regulating processes such as tumor angiogenesis and epithelial–mesenchymal transition (EMT). The gene discussed is IGF2BP2; the disease is cancer.